MGMT testing—the challenges for biomarker-based glioma treatment
University Hospital of Zurich · Erasmus MC Cancer Institute · +2 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
587
total citations
- FWCI
- 21.52
- Percentile
- 100%
- References
- 103
Citations per year
Authors
10Topics & keywords
Topics
Keywords
- Temozolomide
- Glioma
- Medicine
- Methyltransferase
- O-6-methylguanine-DNA methyltransferase
- DNA methylation
- Biomarker
- Context (archaeology)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.